Evidence for Modulatory Sites at the Lipid–Protein Interface of the Human Multidrug Transporter P-Glycoprotein-Reference-Cited by-同舟云学术

Evidence for Modulatory Sites at the Lipid–Protein Interface of the Human Multidrug Transporter P-Glycoprotein

Published:2012-03-22 Issue:13 Volume:51 Page:2852-2866
ISSN:0006-2960
Container-title:Biochemistry
language:en
Short-container-title:Biochemistry

Author:

Mandal Debjani¹,Moitra Karobi¹,Ghosh Debabrata¹,Xia Di²,Dey Saibal¹

Affiliation:

1. Department of Biochemistry, Uniformed Services University School of Medicine, Bethesda, Maryland 20814, United States

2. Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, United States

Publisher

American Chemical Society (ACS)

Subject

Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/bi201479k

Reference72 articles.

1. The multidrug transporter, a double-edged sword.

2. BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTER

3. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells

4. BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER

5. Evidence for a Sav1866‐like architecture for the human multidrug transporter P‐glycoprotein

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of Scutebarbatine B metabolites in rats using UHPLC-Q-Orbitrap-MS/MS and exploration of its mechanism of reversal multidrug resistance in breast cancer by network pharmacology and molecular docking studies;Journal of Pharmaceutical and Biomedical Analysis;2024-08

2. The Tetrahydroisoquinoline Scaffold in ABC Transporter Inhibitors that Act as Multidrug Resistance (MDR) Reversers;Current Topics in Medicinal Chemistry;2022-12

3. Thiopyrans and Their Benzo Derivatives;Comprehensive Heterocyclic Chemistry IV;2022

4. Understanding dihydro-β-agarofuran sesquiterpenes from Tripterygium hypoglaucum as the modulators of multi-drug resistance in HepG2/Adr cells;Biochemical and Biophysical Research Communications;2019-01

5. Aptamers as targeting ligands and therapeutic molecules for overcoming drug resistance in cancers;Advanced Drug Delivery Reviews;2018-09